Abstract
Epilepsy is a common disorder of the brain characterized by spontaneous recurrent seizures, which develop gradually during a process called epileptogenesis. The mechanistic processes underlying the changes of brain tissue and networks toward increased seizure susceptibility are not fully understood. In rodents, injection of kainic acid (KA) ultimately leads to the development of spontaneous epileptic seizures, reflecting similar neuropathological characteristics as seen in patients with temporal lobe epilepsy (TLE). Although this model has significantly contributed to increased knowledge of epileptogenesis, it is technically demanding, costly to operate and hence not suitable for high-throughput screening of anti-epileptic drugs (AEDs). Zebrafish, a vertebrate with complementary advantages to rodents, is an established animal model for epilepsy research. Here, we generated a novel KA-induced epilepsy model in zebrafish larvae that we functionally and pharmacologically validated. KA was administered by pericardial injection at an early zebrafish larval stage. The epileptic phenotype induced was examined by quantification of seizure-like behavior using automated video recording, and of epileptiform brain activity measured via local field potential (LFP) recordings. We also assessed GFP-labeled GABAergic and RFP-labeled glutamatergic neurons in double transgenic KA-injected zebrafish larvae, and examined the GABA and glutamate levels in the larval heads by liquid chromatography with tandem mass spectrometry detection (LC-MS/MS). Finally, KA-injected larvae were exposed to five commonly used AEDs by immersion for pharmacological characterization of the model. Shortly after injection, KA induced a massive damage and inflammation in the zebrafish brain and seizure-like locomotor behavior. An abnormal reorganization of brain circuits was observed, a decrease in both GABAergic and glutamatergic neuronal population and their associated neurotransmitters. Importantly, these changes were accompanied by spontaneous and continuous epileptiform brain discharges starting after a short latency period, as seen in KA rodent models and reminiscent of human pathology. Three out of five AEDs tested rescued LFP abnormalities but did not affect the seizure-like behavior. Taken together, for the first time we describe a chemically-induced larval zebrafish epilepsy model offering unique insights into studying epileptogenic processes in vivo and suitable for high-throughput AED screening purposes and rapid genetic investigations.
Highlights
Epilepsy is a group of neurological diseases characterized by spontaneous recurrent seizures (SRS), resulting from imbalances of excitatory and inhibitory neurotransmission activities in the brain
One of the experimental models that is instrumental to study the mechanistic aspects of epileptogenesis is the kainic acid (KA) rodent model of temporal lobe epilepsy (TLE), which is the most common form of focal epilepsy in adults (Gonzalez Otarula and Schuele, 2020)
We show that injected larvae display whole brain abnormalities followed by spontaneous seizure-like locomotor behavior shortly after KA injection and epileptiform brain discharges after a latency phase, likely due to an altered balance between glutamatergic excitation and GABAergic inhibition
Summary
Epilepsy is a group of neurological diseases characterized by spontaneous recurrent seizures (SRS), resulting from imbalances of excitatory and inhibitory neurotransmission activities in the brain. At the origin of these diseases lies epileptogenesis, a process activated by genetic or acquired factors that is marked by alterations in neuronal excitability and interconnections, most probably as a consequence of structural changes, including cell loss and synaptic reorganization (Pitkanen and Engel, 2014). There is an outstanding need to understand the mechanistic processes underlying the changes of brain tissue and networks toward increased seizure susceptibility (Pitkanen et al, 2015). Even though KA rodent models have substantially increased our understanding of the pathogenesis of SRS, they are technically demanding and costly to operate, and not suitable for high-throughput screening of anti-epileptic drugs (AEDs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.